Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Oh

Showing results (861-870 of 916) with videos related to

Pageof 92
Sort By:
ESMO Open|August 30, 2024
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)E J Kang, Y Yang, S Lee, et al.
British Journal of Cancer|May 9, 2013
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapyD-W Lee, S-W Han, H J Lee, et al.
Cancer Research and Treatment|December 19, 2015
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung CancerY H Joh, T Y Kim, I I Na, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
ESMO Open|June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202A Vogel, V Sahai, A Hollebecque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.
Cell Death and Differentiation|February 28, 2015
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cellsS-H Kim, E-J Kim, M Hitomi, et al.
Journal of Neurosurgery|October 25, 2023
Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patientsRobert C Osorio, Alexander F Haddad, Danielle M Hart, et al.
World Neurosurgery|April 22, 2021
Comparison of Minimally Invasive Total versus Subtotal Resection of Spinal Tumors: A Systematic Review and Meta-AnalysisElliot H Choi, Alvin Y Chan, Andrew D Gong, et al.
The Japanese Journal of Antibiotics|June 30, 1998
[Clinical and bacteriological studies on panipenem/betamipron in pediatrics. Kanagawa Research Group for Infectious Diseases of Children]T Kato, T Goshima, H Akita, et al.
Pageof 92

Showing results (861-870 of 916) with videos related to

Sort By:
Pageof 92
ESMO Open|August 30, 2024
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)E J Kang, Y Yang, S Lee, et al.
British Journal of Cancer|May 9, 2013
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapyD-W Lee, S-W Han, H J Lee, et al.
Cancer Research and Treatment|December 19, 2015
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung CancerY H Joh, T Y Kim, I I Na, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
ESMO Open|June 5, 2024
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202A Vogel, V Sahai, A Hollebecque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2019
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparibP Hammel, H L Kindler, M Reni, et al.
Cell Death and Differentiation|February 28, 2015
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cellsS-H Kim, E-J Kim, M Hitomi, et al.
Journal of Neurosurgery|October 25, 2023
Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patientsRobert C Osorio, Alexander F Haddad, Danielle M Hart, et al.
World Neurosurgery|April 22, 2021
Comparison of Minimally Invasive Total versus Subtotal Resection of Spinal Tumors: A Systematic Review and Meta-AnalysisElliot H Choi, Alvin Y Chan, Andrew D Gong, et al.
The Japanese Journal of Antibiotics|June 30, 1998
[Clinical and bacteriological studies on panipenem/betamipron in pediatrics. Kanagawa Research Group for Infectious Diseases of Children]T Kato, T Goshima, H Akita, et al.
Pageof 92